StockDuty ← Dashboard Jun 20, 2026 06:04 PM ET
CatalystFDA/Bio

PRECIGEN (PGEN) SECURES FDA ORPHAN DRUG EXCLUSIVITY FOR PAPZIMEOS — via YAHOO

Orphan Drug Exclusivity is a significant regulatory catalyst for Precigen's Papzimeos.

What changed
Why it matters
Orphan Drug Exclusivity is a significant regulatory catalyst for Precigen's Papzimeos.
Sources
yahoo
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →